Megan Garlapow, PhD

All articles by Megan Garlapow, PhD

• Simple blood test may spot heart disease risk in PBC

  People with PBC had a notable rate of cardiovascular disease, suggesting heart health deserves routine attention alongside liver care.

• Genetic study links PBC and Crohn’s disease

  Genetic analysis showed Crohn’s disease was linked to a higher risk of developing primary biliary cholangitis (PBC).

• PCSK9 levels signal early autoimmune liver disease

  Patients with primary biliary cholangitis and related autoimmune liver diseases showed higher PCSK9 levels than healthy people.

• Study shows PBC raises risk of small vessel stroke

  Genetic analyses indicate that PBC directly increases the risk of lacunar stroke, suggesting a causal relationship.

• Genetic discovery links ETS1 variant to increased PBC risk

  A genetic variant near the ETS1 gene called rs10893900 increases risk for primary biliary cholangitis (PBC).

• Genetic findings reveal how PBC may weaken muscles

  Researchers found strong genetic connections between primary biliary cholangitis and muscle loss, with liver inflammation a possible driver.

• New drugs are transforming treatment outlook for PBC

  New medications and investigational agents offer more options for patients whose PBC does not respond to standard care.

• Research highlights common risks and treatments in Sjogren’s disease and PBC

  Patients with Sjogren’s syndrome face a higher risk of also developing PBC, with both diseases sharing genetic and immune features.

• Researchers uncover genetic clues driving primary biliary cholangitis risk

  Strong evidence shows that changes in certain immune system genes raise or lower the risk of developing primary biliary cholangitis.

• Global groups rally to mark International PBC Day

  For patients, these initiatives mean greater visibility for their condition, more resources to navigate care, and stronger bonds with others who understand their experience.